The U.S. Pain Foundation recently submitted comments to the Food and Drug Administration (FDA) in response to its request for Guidance for Industry Comments to the Docket regarding the Development of Non-Opioid Analgesics for Acute Pain.
U.S. Pain Foundation’s Docket Comments to the FDA on the Development of Non-Opioid Analgesics for Acute Pain
by US Pain Foundation | May 21, 2022 | Advocacy, News